Evidence map›Paper›PMID 39770554›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B.

Maroua Fattouche, Salah Belaidi, Oussama Abchir, Walid Al-Shaar, Khaled Younes, Muneerah Mogren Al-Mogren, Samir Chtita, Fatima Soualmia, Majdi Hochlaf

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maroua FattoucheGroup of Computational and Medicinal Chemistry, Molecular Chemistry and Environment Laboratory, University of Biskra, BP 145, Biskra 07000, Algeria.
Salah BelaidiGroup of Computational and Medicinal Chemistry, Molecular Chemistry and Environment Laboratory, University of Biskra, BP 145, Biskra 07000, Algeria.
Oussama AbchirLaboratory of Analytical and Molecular Chemistry, Hassan II University of Casablanca, B.P, 7955 Casablanca, Morocco.ORCID 0000-0001-9183-6951
Walid Al-ShaarCollege of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.
Khaled YounesCollege of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.ORCID 0000-0003-0966-2433
Muneerah Mogren Al-MogrenDepartment of Chemistry, Faculty of Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
Samir ChtitaLaboratory of Analytical and Molecular Chemistry, Hassan II University of Casablanca, B.P, 7955 Casablanca, Morocco.ORCID 0000-0003-2344-5101
Fatima SoualmiaProcess Engineering and Environment Laboratory, University of Science and Technology of Oran (USTO), BP 1503, Oran 31000, Algeria.
Majdi HochlafCOSYS/IMSE, Université Gustave Eiffel, Champs-sur-Marne, 77454 Marne-la-Vallée, Cedex 2, France.ORCID 0000-0002-4737-7978

Funding

American University of the Middle East NOT AVAILABLE
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADMETANN-QSARisothiazole derivativesmolecular dockingmolecular dynamicspolymerase NS5B

Identifiers

PMID39770554
PMCPMC11678770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.